Detalhe da pesquisa
1.
Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapy.
J Immunol
; 184(2): 1079-84, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19966210
2.
Induction of angiogenesis by normal and malignant plasma cells.
Blood
; 114(1): 128-43, 2009 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19299335
3.
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma.
J Immunol
; 183(2): 832-40, 2009 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19542363
4.
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma.
Eur J Haematol
; 81(1): 26-35, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18363871
5.
B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
Exp Hematol
; 35(3): 443-53, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17309825
6.
Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
Exp Hematol
; 34(4): 486-96, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16569595
7.
Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 Inhibition.
PLoS One
; 10(6): e0130518, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26110267
8.
Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells.
Cancer Cell
; 28(4): 415-428, 2015 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26461090
9.
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells.
Nat Biotechnol
; 31(1): 71-5, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23242161
10.
Tolerance induction by allogeneic hematopoietic stem cells.
Cell Stem Cell
; 9(2): 87-8, 2011 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21816356
11.
Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
J Immunother
; 32(6): 613-21, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19483648
12.
In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma.
Br J Haematol
; 139(2): 206-16, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17897296
13.
Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis.
J Immunol
; 178(5): 3307-15, 2007 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17312182
14.
Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor.
J Immunol
; 176(11): 6631-9, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16709821